FIELD: organic chemistry, medicine, oncology, pharmacy. SUBSTANCE: invention relates to styrylsulfone compounds of the formula (I) where n = 0 or 1; R1 is taken among group including chlorine, fluorine or bromine atom; R2 is taken among group including chlorine, fluorine and bromine atom; R3 is taken among group including hydrogen and fluorine atom; both radicals R1 and R2 can not mean chlorine atom in the case when R3 represents hydrogen atom; R1 can not mean chlorine atom in the case when R2 represents fluorine atom; R3 represents hydrogen atom in the same compound. Invention describes also pharmaceutical compositions of formulas (II) , (III) and (IV) . Styrylsulfone compounds relating to the present invention inhibit proliferation of breast and prostate tumor cells and induce apoptosis of such tumor cell being without effect on normal cells. EFFECT: enhanced effectiveness of inhibition and apoptosis induction of tumor cells, improved method of treatment. 42 cl, 9 dwg, 5 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REDUCING VISCOSITY OF CRUDE OIL | 2005 |
|
RU2461767C2 |
DENTAL BORER | 2002 |
|
RU2286744C2 |
SYSTEM OF FUEL SPRAY FACILITATED BY ELECTRIC FIELD AND METHOD OF ITS USE | 2007 |
|
RU2469205C2 |
STEM CELLS AND MATRICES OBTAINED FROM ADIPOSE TISSUE | 2000 |
|
RU2306335C2 |
MODIFIED DENDRITE CELLS AND THEIR USE IN TREATMENT OF MALIGNANT TUMOURS | 2008 |
|
RU2484132C2 |
ONCOLYTIC HSV-VECTOR | 2014 |
|
RU2719190C2 |
PREDICTING AND PREVENTING PREECLAMPSIA | 2009 |
|
RU2538661C2 |
CANCER TREATMENT USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANISED ANTI-EGFRvIII ANTIBODY | 2014 |
|
RU2708032C2 |
MODIFIED DENDRITIC CELLS AND THEIR APPLICATION FOR MALIGNANT TUMOURS TREATMENT | 2013 |
|
RU2644210C2 |
MODIFIED DENDRITIC CELLS AND USE THEREOF IN TREATING MALIGNANT TUMOURS | 2017 |
|
RU2711606C2 |
Authors
Dates
2003-04-10—Published
1998-10-01—Filed